248 related articles for article (PubMed ID: 31609176)
1. Performance Characteristics of Clinical Staging Modalities for Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Tema G; Patel HD; Gupta M; Sharma R; Zhang A; Bass EB
J Urol; 2020 May; 203(5):894-901. PubMed ID: 31609176
[TBL] [Abstract][Full Text] [Related]
2. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
3. Comparison between clinical and pathological staging in low stage nonseminomatous germ cell testicular tumors.
Pizzocaro G; Nicolai N; Salvioni R; Piva L; Faustini M; Zanoni F; Milani A
J Urol; 1992 Jul; 148(1):76-9. PubMed ID: 1319508
[TBL] [Abstract][Full Text] [Related]
4. Imaging studies for germ cell tumors.
Sohaib SA; Cook G; Koh DM
Hematol Oncol Clin North Am; 2011 Jun; 25(3):487-502, vii. PubMed ID: 21570604
[TBL] [Abstract][Full Text] [Related]
5. Imaging of testicular germ cell tumours.
Dalal PU; Sohaib SA; Huddart R
Cancer Imaging; 2006 Sep; 6(1):124-34. PubMed ID: 16966068
[TBL] [Abstract][Full Text] [Related]
6. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging.
Wakileh GA; Ruf C; Heidenreich A; Dieckmann KP; Lisson C; Prasad V; Bolenz C; Zengerling F
World J Urol; 2022 Feb; 40(2):307-315. PubMed ID: 34779884
[TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
8. State of the art in germ cell tumor imaging.
Secil M; Altay C; Basara I
Urol Oncol; 2016 Mar; 34(3):156-64. PubMed ID: 26215982
[TBL] [Abstract][Full Text] [Related]
9. [Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
Schriefer P; Hartmann M; Oechsle K; Meyer CP; Klutmann S; Fisch M; Bokemeyer C; Oing C
Urologe A; 2019 Apr; 58(4):418-423. PubMed ID: 30374517
[TBL] [Abstract][Full Text] [Related]
10. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of preoperative studies in staging nonseminomatous germ cell testicular tumors.
Sago AL; Montie JE; Novicki DE; Weber CH
Urology; 1978 Oct; 12(4):420-2. PubMed ID: 213865
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early-stage nonseminomatous germ cell tumors.
Su D; Faiena I; Tokarz R; Bramwit M; Weiss RE
Urology; 2015 Jan; 85(1):141-6. PubMed ID: 25530376
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
Zhao JY; Ma XL; Li YY; Zhang BL; Li MM; Ma XL; Liu L
Asian Pac J Cancer Prev; 2014; 15(8):3525-31. PubMed ID: 24870751
[TBL] [Abstract][Full Text] [Related]
14. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in imaging of male reproductive tract malignancies.
Fütterer JJ; Spermon JR
Cancer Treat Res; 2008; 143():331-64. PubMed ID: 18619225
[No Abstract] [Full Text] [Related]
16. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
[TBL] [Abstract][Full Text] [Related]
17. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
Lassen U; Daugaard G; Eigtved A; Højgaard L; Damgaard K; Rørth M
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):396-402. PubMed ID: 12634968
[TBL] [Abstract][Full Text] [Related]
18. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
Riedinger CB; Labbate C; Werntz RP; Eggener SE
Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
[No Abstract] [Full Text] [Related]
19. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
20. Testicular germ cell tumors: diagnosis, management, and the potential for cure.
Katz ME; Grosbach AB; Wein A; Glick JH
Cancer Clin Trials; 1978; 1(4):247-71. PubMed ID: 93029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]